Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
ChEBI | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H24N2 |
Molar mass | 280.415 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Ibogamine is an anti-convulsant, anti-addictive, CNS stimulant alkaloid found in Tabernanthe iboga and Crepe Jasmine (Tabernaemontana divaricata).[1][2][3] Basic research related to how addiction affects the brain has used this chemical.[4]
Ibogamine persistently reduced the self-administration of cocaine and morphine in rats.[5] The same study found that ibogamine (40 mg/kg) and coronaridine (40 mg/kg) did not produce "any tremor effects in rats that differ significantly from saline control". While the related alkaloids ibogaine (20–40 mg/kg), harmaline (10–40 mg/kg) and desethylcoronaridine (10–40 mg/kg) were "obviously tremorgenic".[5]
Ibogamine can be prepared from one-step demethoxycarbonylation process through coronaridine.[6]
Like ibogaine, it has seems to have similar pharmacology. It has effects on KOR,[7] NMDAR, nAChR[8] and serotonin sites.[9] It also inhibits acetylcholinesterase and butyrylcholinesterase.[10]
Treatment of drug dependence (N07B) | |
---|---|
Nicotine dependence |
|
Alcohol dependence | |
Opioid dependence | |
Benzodiazepine dependence |
|